Cevoglitazar is a potent dual agonist of PPARα and PPARγ, designed for oral administration. It effectively reduces food intake, body weight, and fasting plasma insulin levels in preclinical models such as obese mice and cynomolgus monkeys. This compound holds promise for research into diabetes and obesity-related disorders, facilitating exploration of metabolic pathways and therapeutic strategies in these conditions.
Cevoglitazar is a potent dual agonist of PPARα and PPARγ, designed for oral administration. It effectively reduces food intake, body weight, and fasting plasma insulin levels in preclinical models such as obese mice and cynomolgus monkeys. This compound holds promise for research into diabetes and obesity-related disorders, facilitating exploration of metabolic pathways and therapeutic strategies in these conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
